Trial Profile
An Exploration of the Effects of the Dopamine Agonist Pramipexole on Binge Antecedants, Binge Frequency, and Weight in Binge Eating Disorder.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 11 May 2013
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary)
- Indications Binge-eating disorder
- Focus Therapeutic Use
- 30 Apr 2010 New trial record